Myelitis  >>  dalfampridine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dalfampridine / Generic mfg.
NCT01446575: Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis

Terminated
4
6
US
Dalfampridine, Ampyra, Placebo controlled, Sugar pill
Johns Hopkins University, Acorda Therapeutics
Transverse Myelitis
11/13
11/13

Download Options